Physician Data Query

Last uploaded: August 28, 2024
Preferred Name

tranexamic acid
Synonyms

Cyklokapron

Definitions

A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, transexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47765" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47765" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000453549

altLabel

Cyklokapron

cui

C0040613

C0591311

DATE FIRST PUBLISHED

2005-10-24

Date last modified

2006-09-28

definition

A synthetic derivative of the amino acid lysine with antifibrinolytic activity. With strong affinity for the five lysine-binding sites of plasminogen, transexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47765" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47765" NCI Thesaurus)

LT

TRD

NCI ID

C47765

notation

CDR0000453549

ORIG STY

Drug/agent

prefLabel

tranexamic acid

tui

T109

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Mapping To Ontology Source
http://purl.bioontology.org/ontology/NDFRT/N0000148271 NDFRT CUI
http://purl.bioontology.org/ontology/RCD/x02YS RCD CUI
http://purl.bioontology.org/ontology/RXNORM/10691 RXNORM CUI
http://purl.bioontology.org/ontology/ATC/B02AA02 ATC CUI
http://purl.bioontology.org/ontology/SNOMEDCT/109006003 SNOMEDCT CUI
http://purl.bioontology.org/ontology/MSHFRE/D014148 MSHFRE CUI
http://purl.bioontology.org/ontology/SCTSPA/386960009 SCTSPA CUI
http://purl.bioontology.org/ontology/MESH/D014148 MESH CUI
http://purl.bioontology.org/ontology/SNOMEDCT/386960009 SNOMEDCT CUI
http://purl.bioontology.org/ontology/NDFRT/N0000006887 NDFRT CUI
http://purl.bioontology.org/ontology/VANDF/4020569 VANDF CUI
http://purl.bioontology.org/ontology/NDDF/002073 NDDF CUI
http://purl.bioontology.org/ontology/RCD/bw3.. RCD CUI
http://purl.bioontology.org/ontology/SCTSPA/109006003 SCTSPA CUI
http://purl.bioontology.org/ontology/RXNORM/151568 RXNORM CUI
http://purl.bioontology.org/ontology/MESH/D014148 MESH CUI
http://www.drugbank.ca/drugs/DB00302 FTC LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148271 NDFRT LOOM
http://purl.bioontology.org/ontology/RXNORM/10691 RXNORM LOOM
http://purl.bioontology.org/ontology/ATC/B02AA02 ATC LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D014148 RH-MESH LOOM
http://purl.jp/bio/4/id/200906016175942637 IOBC LOOM
http://www.semanticweb.org/ontologies/2010/10/BPO.owl#tranexamic_acid BHO LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0040613 OCHV LOOM
http://purl.obolibrary.org/obo/OMIT_0014988 OMIT LOOM
http://purl.bioontology.org/ontology/MESH/D014148 MESH LOOM
http://purl.obolibrary.org/obo/MESH_D014148 BERO LOOM
http://www.phoc.org.cn/pmo/class/PMO_00016539 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386960009 SNOMEDCT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#12443 OCHV LOOM
http://purl.bioontology.org/ontology/VANDF/4020569 VANDF LOOM
http://purl.obolibrary.org/obo/NCIT_C47765 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_48669 NIFSTD LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47765 NCIT LOOM
http://purl.bioontology.org/ontology/NDDF/002073 NDDF LOOM
http://www.co-ode.org/ontologies/galen#TranexamicAcid GALEN LOOM
http://stirdf.jst.go.jp/id/200907022141280957 IOBC LOOM
https://go.drugbank.com/drugs/DB00302 MDM LOOM
http://purl.bioontology.org/ontology/RCD/bw3.. RCD LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#D02.241.223.268.860 RH-MESH LOOM